Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report - Top-Institutions - MDSpire

Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report

  • By

  • Man Ding

  • Bo Yin

  • Jiajia Yao

  • Yin Liu

  • Hongjuan Dong

  • Zuneng Lu

  • May 21, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology

  • #2

    Medical University Vienna
    Medical University Vienna

    Vienna, Austria

    Key Differentiators

    • Neurology

  • #3

    Tohoku University School of Medicine
    Tohoku University School of Medicine

    Sendai, Japan

    Key Differentiators

    • Neurology

Original Source(s)

Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report

  • by Man Ding, Bo Yin, Jiajia Yao, Yin Liu, Hongjuan Dong, Zuneng Lu

  • May 21, 2026

Related Content

CGRP Therapies Reduced Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies

Can a Blood Count Predict Dementia?

Study explores a potential hematological risk marker using real-world data

  • May 20, 2026

  • 2 min
Asthma, Rhinitis Tied to Parkinson's Risk

A nationwide Korean cohort study found modestly higher Parkinson's disease incidence among patients with asthma or allergic rhinitis, with stronger associations observed among patients with greater allergic disease burden.